About: CytRx

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

CytRx Corp. (Nasdaq: CYTR) is a biopharmaceutical research and development oncology company based in Los Angeles, California. The CytRx oncology pipeline includes clinical trials involving their lead drug aldoxorubicin. Aldoxorubicin (formerly INNO-206) is a modified form of doxorubicin, the popular anthracycline chemotherapeutic agent known as "red death".

Property	Value
dbo:abstract	CytRx Corp. (Nasdaq: CYTR) is a biopharmaceutical research and development oncology company based in Los Angeles, California. The CytRx oncology pipeline includes clinical trials involving their lead drug aldoxorubicin. Aldoxorubicin (formerly INNO-206) is a modified form of doxorubicin, the popular anthracycline chemotherapeutic agent known as "red death". Anthracyclines are a class of drugs that are among the most commonly used agents in the treatment of cancer. Doxorubicin, the first anthracycline to gain approval, has demonstrated efficacy in a wide variety of cancers including breast cancer, lung cancer, sarcomas, and lymphomas. However, doxorubicin is associated with side effects such as myelosuppression, gastrointestinal disorders, mucositis, stomatitis, cumulative cardiotoxicity and extravasation. (en)
dbo:wikiPageExternalLink	http://www.cytrx.com/aldoxorubicin http://www.cytrx.com/
dbo:wikiPageID	5605714 (xsd:integer)
dbo:wikiPageLength	5003 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1019214696 (xsd:integer)
dbo:wikiPageWikiLink	dbr:California dbc:Companies_based_in_Los_Angeles dbr:Anthracycline dbr:Research_and_development dbc:Companies_listed_on_the_Nasdaq dbr:Conflict_of_interest dbr:Russell_Microcap_Index dbr:Galena_Biopharma dbr:Los_Angeles dbr:Aldoxorubicin dbr:Doxorubicin dbr:Forbes.com dbc:Health_care_companies_based_in_California dbr:Hydrazone dbc:Pharmaceutical_companies_of_the_United_States dbr:Biopharmaceutical dbr:Seeking_Alpha dbr:CNNMoney dbr:Stock_promoter dbr:Motley_Fool
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Infobox_company dbt:Primary_sources dbt:Reflist dbt:Pharmaceutical_companies_of_the_United_States
dcterms:subject	dbc:Companies_based_in_Los_Angeles dbc:Companies_listed_on_the_Nasdaq dbc:Health_care_companies_based_in_California dbc:Pharmaceutical_companies_of_the_United_States
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatCompaniesBasedInLosAngeles,California yago:WikicatCompaniesListedOnNASDAQ yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates
rdfs:comment	CytRx Corp. (Nasdaq: CYTR) is a biopharmaceutical research and development oncology company based in Los Angeles, California. The CytRx oncology pipeline includes clinical trials involving their lead drug aldoxorubicin. Aldoxorubicin (formerly INNO-206) is a modified form of doxorubicin, the popular anthracycline chemotherapeutic agent known as "red death". (en)
rdfs:label	CytRx (en)
owl:sameAs	freebase:CytRx http://api.nytimes.com/svc/semantic/v2/concept/name/nytd_porg/Cytrx%20Corporation yago-res:CytRx wikidata:CytRx https://global.dbpedia.org/id/4ibT2
skos:closeMatch	http://www.grid.ac/institutes/grid.422976.c
prov:wasDerivedFrom	wikipedia-en:CytRx?oldid=1019214696&ns=0
foaf:homepage	http://www.cytrx.com/
foaf:isPrimaryTopicOf	wikipedia-en:CytRx
is dbo:wikiPageRedirects of	dbr:Cytrx dbr:CytRx_Corp. dbr:CytRx_Corporation
is dbo:wikiPageWikiLink of	dbr:List_of_pharmaceutical_companies dbr:List_of_pharmaceutical_compound_number_prefixes dbr:Bafetinib dbr:Cytrx dbr:Aldoxorubicin dbr:Arimoclomol dbr:Phio_Pharmaceuticals dbr:CytRx_Corp. dbr:CytRx_Corporation
is foaf:primaryTopic of	wikipedia-en:CytRx